Manufacturer record
Signoret Pharmaceuticals Pvt.Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Signoret Pharmaceuticals Pvt.Ltd (Punjab) were declared Not of Standard Quality between May 2023 and February 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Signoret Pharmaceuticals Pvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| SITAGLIPTIN PHOSPHATE 50 + METFORMIN 500MG TABLETS (LanZsita-M) | SP/T/76 1Mfg ? · Exp ? | For the received sample SITAGLIPTIN PHOSPHATE 50 + METFORMIN 500MG TABLETS (LanZsita-M), The label is mentioned as ?Approved colour used? but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules,1945 was not mentioned.-MisbrandedMisbranded | PuducherryState lab | Feb 2025 |
| SITAGLIPTIN IP 100mg TABLETS (LanZsita 100) | SP/T/83 8Mfg ? · Exp ? | For the received sample Sitagliptin IP 100mg Tablets (LanZsita 100), The label is mentioned as ?Approved colour used? but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules ,1945 was not mentioned.- MisbrandedMisbranded | PuducherryState lab | Feb 2025 |
| RABEPRAZOLE ENTERIC COATED TABLETS IP 20mg (Rabelanz-20) | SP/T/76 2Mfg ? · Exp ? | For the received sample Rabeprazole Enteric Coated Tablets IP 20mg, 1. Chipping and Rough surface defect was observed which should not be present as per Drugs & Cosmetics (Amendment) Act, 2008 of DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No. (V) Chipping and (Vii) Rough surface. 2. Cracking of the coating defect was observed which should not be present as prescribed under rule 124B of the Drugs Rules ,1945. 3. The label is mentioned as ?Approved colour used? but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules ,1945 was not mentioned. 4. Does not comply with respect to test for Disintegration and Assay - NSQAssay | PuducherryState lab | Feb 2025 |
| PIOGLITAZONE 15, GLIMEPIRIDE 2mg+ METFORMIN 500 mg (Lanzpride- PM2) | SP/T/74 3Mfg ? · Exp ? | For the received sample PIOGLITAZONE 15, GLIMEPIRIDE 2mg+ METFORMIN 500 mg (Lanzpride-PM2), 1. The label is mentioned as ?Approved colour used? but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules,1945 was not mentioned. 2.For the received sample PIOGLITAZONE 15, GLIMEPIRIDE 2mg+ METFORMIN 500 mg (Lanzpride-PM2), On visual inspection pink coloured spots were observed on other side (white colour) of the tablets .-MisbrandedMisbranded | PuducherryState lab | Feb 2025 |
| Paracetamol, Phenylphrine Hydrochloride, Diphenhydramine Hydrochloride and Caffeine Tablets (Syscold Tablets) | SPT?192Mfg 2022-01 · Exp 2023-12 | Disintegration test and Assay of Phenylephrine HydrochlorideAssay | RDTL ChandigarhState lab | May 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.